Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Jan 28, 2005; 11(4): 476-481
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.476
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.476
Figure 3 Receiver operating curves of type IV collagen, PIIIP, HA and YKL-40 for predicting stages greater than F1.
YKL-40 and HA exceeded those of PIIIP and type IV collagen (YKL-40, AUC = 0.809; HA, AUC = 0.805).
- Citation: Saitou Y, Shiraki K, Yamanaka Y, Yamaguchi Y, Kawakita T, Yamamoto N, Sugimoto K, Murata K, Nakano T. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World J Gastroenterol 2005; 11(4): 476-481
- URL: https://www.wjgnet.com/1007-9327/full/v11/i4/476.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i4.476